Source: PR Newswire

Press Release: Seahorse Bioscience : Seahorse Bioscience XF Technology Reaches 500th Citation in Cancer Research

BILLERICA, Mass., Jan. 11, 2016 /PRNewswire/ -- Seahorse Bioscience, a part of Agilent Technologies and the leader in metabolic analyzers and assay kits for measuring cell metabolism, has reached its 500th citation in cancer research. Published in Scientific Reports, the paper...

Read full article »
Est. Annual Revenue
$25-100M
Est. Employees
100-250
Jay Teich's photo - CEO of Seahorse Bioscience

CEO

Jay Teich

CEO Approval Rating

61/100

Read more